Arcus Biosciences (RCUS) PT Raised to $54 at Citi
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $30.30 +2.64%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Arcus Biosciences (NYSE: RCUS) to $54.00 (from $47.00) while maintaining a Buy rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Cummins (CMI) PT Lowered to $675 at Jefferies
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
